MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The right hemisphere inhibitory network in patients with asymmetrical Parkinson’s disease: An fMRI study

    F. Lazoya, I. Obeso, R. Gonzales Redondo, F. Villagra, E. Luis, J. Obeso, M. Jahanshahi, M. Pastor (Pamplona, Spain)

    Objective: The aim of our study was to identify the neural substrates of inhibitory processing on the stop signal task in patients with predominantly left…
  • 2019 International Congress

    11C-PBB3 PET in PD: does alpha-synuclein pathology start in axonal terminals?

    M. Matarazzo, A. Pérez-Soriano, V. Sossi, N. Vafai, E. Shahinfard, K. Ju-Chieh Cheng, J. Mckenzie, N. Neilson, Q. Miao, H. Shinotoh, M. Higuchi, A. Stoessl (Vancouver, BC, Canada)

    Objective: To use 11C-PBB3 PET binding to monitor alpha-synuclein (a-syn) pathology in PD subjects in vivo. Background: In previous work we have shown binding of…
  • 2019 International Congress

    Structural connectivity changes in G2019S-LRRK2 gene mutation carriers without manifest Parkinson’s disease

    G. Pagano, P. Vickers, J. Schulz, H. Wilson, M. Politis (London, United Kingdom)

    Objective: We hypothesised that abnormal sprouting of serotonergic terminals in the hypothalamus may lead to abnormal structural connectivity, which can be measured with diffusion tensor…
  • 2019 International Congress

    In vivo increased striatal iron deposition in Parkinson’s Disease Dementia and Dementia with Lewy Body

    S. Rota, T. Yousaf, H. Wilson, G. Dervenoulas, G. Pagano, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: To evaluate iron deposition with susceptibility weighted imaging (SWI) MRI in the basal ganglia of patients affected by Parkinson’s Disease Dementia (PDD) and Dementia…
  • 2019 International Congress

    Neurofeedback-guided motor imagery in Parkinson’s disease

    S. Tinaz, M. Elfil, J. Lemere, S. Basu, R. Sinha, D. Scheinost, M. Hampson (New Haven, CT, USA)

    Objective: We tested whether patients with Parkinson’s disease (PD) can increase the functional connectivity (FC) between the right insula (rIns) and dorsomedial frontal cortex (dmFC)…
  • 2019 International Congress

    Effects of exergaming on attentional deficits and dual-tasking in Parkinson’s disease

    E. Schaeffer, J. Busch, B. Roeben, S. Otterbein, P. Saraykin, E. Leks, I. Liepelt-Scarfone, M. Synofzik, M. Elshehabi, W. Maetzler, C. Hansen, S. Andris, D. Berg (66041, Germany)

    Objective: To evaluate the effects of exergaming in a controlled six week intervention trial to improve attention-based deficits and dual-tasking in PD when compared to…
  • 2019 International Congress

    Assessing the validity and reliability of MANAGE-PD tool to identify patients with Parkinson’s disease inadequately controlled on oral medications – Results from an international survey of general neurologists and movement disorder specialists

    A. Antonini, P. Odin, Y. Jalundhwala, P. Schmidt, A. Skalicky, L. Kleinman, J. Zamudio, K. Onuk, P. Kukreja, Y. Bao, F. Cubillos, H. Fernandez (Padua, Italy)

    Objective: To evaluate the validity and reliability of MANAGE-PD tool. Background: Timely identification of advancing symptoms in patients with Parkinson’s Disease (PD), thereby improving opportunities…
  • 2019 International Congress

    Arm levitation as an early manifestation in MELAS syndrome: A case report

    D. Gunal, I. Midi, E. Erdil (Istanbul, Turkey)

    Objective: Arm levitation in MELAS  syndrome Background: MELAS syndrome has broad manifestations including stroke-like episodes, dementia, epilepsy, lactic academia, myopathy, recurrent headaches, hearing impairment, diabetes and short…
  • 2019 International Congress

    Impulse control and repetitive behavior disorders are more common in PD patients with levodopa-induced dyskinesias

    F. Paolini Paoletti, N. Tambasco, G. Cappelletti, P. Eusebi, S. Simoni, P. Nigro, E. Brahimi, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: Our aim was to evaluate the prevalence of impulse control and repetitive behavior disorders (ICRB) in patients affected by Parkinson's disease (PD) with and without levodopa-induced…
  • 2019 International Congress

    Adult-onset stereotypy — An atypical presentation of frontotemporal dementia

    C. Walsh, L. Brennan, J. Ratliff (Philadelphia, PA, USA)

    Objective: Describe a case of adult-onset stereotypy with abulia. Background: Stereotypy is a non-goal directed but distractible behavior repeated continuously. While common in the pediatric…
  • « Previous Page
  • 1
  • …
  • 161
  • 162
  • 163
  • 164
  • 165
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley